Unveiling the Investors’ Perspective to Accelerate Your Path to Raising Capital

Time: 11:30 am
day: Pre-Conference Workshop Day


The current economic downturn is making it increasingly difficult to raise early investment, with investors weighing up the risks of novel and emerging industries more than ever before. It is vital for early start up biotechs and VC firms to come together to map the current cell therapy landscape, and how to position novel in vivo pipelines as an invaluable investment.

Attend this workshop to:

• Understand the current investor landscape

• Delve into the priorities of VC firms, angel investors and pharma venture funds as they discuss their interests/excitement around the in-vivo space